Morgan Stanley backs Celldex Therapeutics for growth with barzolvolimab's market-leading potential in chronic urticaria. Read ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

Cash Position & Operating Runway: As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

A migraine attack is more than a headache. It can derail your entire day.

The cause of rashes can vary, spanning allergic reactions, infections, autoimmune diseases and environmental irritants.

Medically reviewed by Jurairat J. Molina, MD Allergies occur when your immune system overreacts to harmless substances like ...

ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...

Strawberries may modestly enhance processing speed and lower systolic blood pressure in older adults, but they do not ...

Best remedies for hay fever and allergies in the UK - Suffering with seasonal allergies? See them off with one of our hay ...

U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and weighing ...